SCHEMBL3151324

SCHEMBL3151324

CC(CC(C)(C)c1ccc(N)cc1)c1ccc(N)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
ALDH1A1 P00352 2/20 0.41
HPGD P15428 1/20 0.41
MAPK1 P28482 1/20 0.41
GRIA4 P48058 3/20 0.38
PDE2A O00408 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GRIN2D O15399 1/20 0.35
GRIN3B O60391 1/20 0.35
GRIN1 Q05586 1/20 0.35
GRIN2A Q12879 1/20 0.35
GRIN2B Q13224 1/20 0.35
GRIN2C Q14957 1/20 0.35
GRIN3A Q8TCU5 1/20 0.35
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2C19 P33261 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10716629 0.92 MAPT (0.63) MAPTNPC1RAB9AALDH1A1HPGD
SCHEMBL10794218 0.82 TSHR (0.43) MAPTNPC1RAB9AGRIA4RIPK1
SCHEMBL3480352 0.81 SHBG (0.52) MAPTALDH1A1HPGDTDP1CYP1A2
SCHEMBL12384045 0.81 PDE2A (0.43) PDE2A
SCHEMBL21671652 0.80 NPC1 (0.49) MAPTNPC1RAB9AALDH1A1HPGD
SCHEMBL23409249 0.80 ACE (0.35) MAPTNPC1RAB9AALDH1A1GRIA4
SCHEMBL19012408 0.79 ALDH1A1 (0.44) MAPTNPC1RAB9AALDH1A1MAPK1
SCHEMBL21933684 0.78 PDE2A (0.37) GRIA4PDE2AGRIN2DGRIN3BGRIN1
SCHEMBL9359862 0.77 MAOB (0.49) MAPTNPC1RAB9AALDH1A1HPGD
SCHEMBL11019015 0.77 MAPT (0.49) MAPTNPC1RAB9AALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-57175148-A None JP disclosed
CN-114008525-B Method for producing purified resist composition, method for forming resist pattern, and purified resist composition 东京应化工业株式会社 2025-05-23 CN disclosed
US-20250153114-A1 POLYIMIDE-CONTAINING FILTRATION MEMBRANE, FILTERS, AND METHODS ENTEGRIS, INC. 2025-05-15 US disclosed
US-20250110406-A1 METHOD OF PRODUCING RESIST COMPOSITION PURIFIED PRODUCT, RESIST PATTERN FORMING METHOD, AND RESIST COMPOSITION PURIFIED PRODUCT TOKYO OHKA KOGYO CO LTD (JP) 2025-04-03 US disclosed
WO-2025053071-A1 POROUS FILM AND METHOD FOR PRODUCING POROUS FILM 東京応化工業株式会社 2025-03-13 WO disclosed
CN-119552505-A Composition for producing porous film, method for producing porous film, and porous film 东京应化工业株式会社 2025-03-04 CN disclosed
CN-119503513-A Winding device, film winding method, and method for producing porous imide resin film 东京应化工业株式会社 2025-02-25 CN disclosed
CN-119503516-A Slitting machine and system for manufacturing porous imide resin film 东京应化工业株式会社 2025-02-25 CN disclosed
CN-107249720-B Method for purifying liquid, method for producing chemical liquid or cleaning liquid, filter medium, and filter device 东京应化工业株式会社 2025-01-10 CN disclosed
US-12186715-B2 Production method for resist composition purified product, resist pattern forming method, and resist composition purified product TOKYO OHKA KOGYO CO., LTD. (JP) 2025-01-07 US disclosed
US-5753407-A Polyamic acid composition KABUSHIKI KAISHA TOSHIBA (JP) 1998-05-19 US disclosed
US-5585217-A Polyamic acid composition KABUSHIKI KAISHA TOSHIBA (JP) 1996-12-17 US disclosed
US-5518864-A PHOTOSENSITIVE, QUINONE DIAZIDE KABUSHIKI KAISHA TOSHIBA (JP) 1996-05-21 US disclosed
EP-0431971-B1 Photosensitive composition and resin-encapsulated semiconductor device TOSHIBA KK (JP) 1995-07-19 EP disclosed
EP-0431971-A2 Photosensitive composition and resin-encapsulated semiconductor device KABUSHIKI KAISHA TOSHIBA (JP) 1991-06-12 EP disclosed
JP-S57175148-A PREPARATION OF 2-METHYL-2,4-BIS-(4-AMINOPHENYL) PENTANE MITSUI TOATSU CHEM INC 1982-10-28 JP disclosed
US-4186145-A Process for the hydrogenation of an aromatic amine and the supported ruthenium catalyst used in the process BAYER AKTIENGESELLSCHAFT (DE) 1980-01-29 US disclosed
US-4161492-A HYDROGENATION OF AROMATIC AMINES, RUTHENIUM CATALYST, SUPPORT OF CHROMIUM AND MANGANESE HYDROXIDES OR OXIDES BAYER AKTIENGESELLSCHAFT (DE) 1979-07-17 US disclosed
EP-0001425-A1 Supported ruthenium catalyst, process for its preparation, and its use as a hydrogenation catalyst BAYER AG (DE) 1979-04-18 EP disclosed
US-4049584-A HYDROGENATION CATALYST BAYER AKTIENGESELLSCHAFT (DT) 1977-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12186715-B2 Production method for resist composition purified product, resist pattern forming method, and resist composition purified product PUF60, RIOK2, SLC11A2 MAPT 2939/4885NPC1 3418/4885RAB9A 1882/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.